Lesion distribution and prognosis of renal cell carcinoma bone metastasis: A novel evaluation model based on random survival forests
- PMID: 41518076
- DOI: 10.1002/ijc.70320
Lesion distribution and prognosis of renal cell carcinoma bone metastasis: A novel evaluation model based on random survival forests
Abstract
The prognostic value of lesion distribution in renal cell carcinoma bone metastasis (RCC-BM) is unclear. This study aimed to quantify the association between BM distribution and prognosis in RCC-BM patients and to employ a predictive model based on the random survival forests (RSF) algorithm. At first BM diagnosis, 122 patients were stratified by Memorial Sloan-Kettering Cancer Center (MSKCC)/Motzer risk score and classified into locoregional (21.3%), stochastic (56.6%), and extensive (22.1%) groups based on bone lesion distribution. Spinal and pelvic involvement was observed in 39.3% and 35.2% of patients. Univariate, logistic regression, and Kaplan-Meier survival analyses indicated that locoregional spread, spinal involvement (odds ratio [OR] 3.30; 95% confidence interval [CI] 1.20-9.09), and advanced age (OR 1.04; 95% CI 1.00-1.08; p < .05) correlated with higher risk stratifications, while pelvic metastasis was linked to shorter median overall survival (32 vs. 49 months; p < .05). The RSF model was trained in 70% and validated in 30% of the series, incorporating spatial lesion involvement (pelvic, spinal, and upper extremities involvement), MSKCC/Motzer score, and age as principal contributing variables. Time-dependent area under the curve (AUC) values achieved in single-split validation for 1- and 3-year survival were 0.90 and 0.87. Consistent performance was observed across 100 repeated splits, with median AUCs of 0.89, 0.86, and 0.89 for 1-, 3-, and 5-year survival, respectively. A cut-off value of 15.03 effectively separated high- and low-risk groups (p < .05). RSF demonstrated superior accuracy over Cox regression (median AUC 0.89 vs. 0.59 for 1-year survival). Overall, integrating bone lesion patterns into RSF modeling facilitates personalized prognosis and supports more precise care in RCC-BM.
Keywords: lesion distribution; predictive model; random survival forests; renal cell carcinoma bone metastasis.
© 2026 UICC.
References
REFERENCES
-
- Chandrasekar T, Klaassen Z, Goldberg H, Kulkarni GS, Hamilton RJ, Fleshner NE. Metastatic renal cell carcinoma: patterns and predictors of metastases—a contemporary population‐based series. Urol Oncol. 2017;35(11):661.e7‐661.e14. doi:10.1016/j.urolonc.2017.06.060
-
- Huang Z, Du Y, Zhang X, Liu SJ, Xu T. Clinical and pathological analysis of renal cell carcinoma bone metastasis. J Peking Univ (Health Sci). 2018;50(5):811‐815. doi:10.19723/j.issn.1671‐167X.2018.05.008
-
- Ivanyi P, Koenig J, Trummer A, et al. Does the onset of bone metastasis in sunitinib‐treated renal cell carcinoma patients impact the overall survival. World J Urol. 2016;34(7):909‐915. doi:10.1007/s00345‐015‐1707‐0
-
- Fottner A, Szalantzy M, Wirthmann L, et al. Bone metastases from renal cell carcinoma: patient survival after surgical treatment. BMC Musculoskelet Disord. 2010;11(1):145. doi:10.1186/1471‐2474‐11‐145
-
- Mosele GR, Caggiari G, Scarpa RM, Doria C. The treatment of vertebral metastases from renal cell carcinoma: a retrospective study. Minerva Urol Nefrol. 2017;69(2):166‐172. doi:10.23736/S0393‐2249.16.02809‐5
Grants and funding
LinkOut - more resources
Full Text Sources
